Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bernstein

Showing results (861-870 of 913) with videos related to

Pageof 92
Sort By:
Blood|February 7, 2009
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximabShannon P Hilchey, Ollivier Hyrien, Tim R Mosmann, et al.
Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.
Blood|December 15, 2007
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignanciesNancy L Bartlett, Anas Younes, Matthew H Carabasi, et al.
Blood|February 11, 2012
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivativesSteven H Bernstein, Sundararajan Venkatesh, Min Li, et al.
American Journal of Diseases of Children (1960)|May 1, 1992
Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US childrenH H Bernstein, E P Rothstein, M E Pichichero, et al.
Biological Psychiatry|October 4, 2005
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial reportA John Rush, Ira H Bernstein, Madhukar H Trivedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomasJonathan W Friedberg, Daruka Mahadevan, Erin Cebula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
Journal of Affective Disorders|March 25, 2008
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depressionTrisha Suppes, Lauren B Marangell, Ira H Bernstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Pageof 92

Showing results (861-870 of 913) with videos related to

Sort By:
Pageof 92
Blood|February 7, 2009
Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximabShannon P Hilchey, Ollivier Hyrien, Tim R Mosmann, et al.
Seminars in Oncology|February 24, 2005
Phase I study for poor-prognosis lymphoma: augmentation of the "BEAM" regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary reportG L Phillips, C N Abboud, S H Bernstein, et al.
Blood|December 15, 2007
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignanciesNancy L Bartlett, Anas Younes, Matthew H Carabasi, et al.
Blood|February 11, 2012
The mitochondrial ATP-dependent Lon protease: a novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivativesSteven H Bernstein, Sundararajan Venkatesh, Min Li, et al.
American Journal of Diseases of Children (1960)|May 1, 1992
Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US childrenH H Bernstein, E P Rothstein, M E Pichichero, et al.
Biological Psychiatry|October 4, 2005
An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial reportA John Rush, Ira H Bernstein, Madhukar H Trivedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2013
Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomasJonathan W Friedberg, Daruka Mahadevan, Erin Cebula, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2009
Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsivenessShannon P Hilchey, James J Kobie, Mathew R Cochran, et al.
Journal of Affective Disorders|March 25, 2008
A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depressionTrisha Suppes, Lauren B Marangell, Ira H Bernstein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 30, 2011
Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin's lymphoma (HL) in the ABVD therapeutic eraSarah F Keller, Jennifer L Kelly, Elizabeth Sensenig, et al.
Pageof 92